These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 152490)

  • 1. Evidence for suppressor cells and reduced CML induction by the donor in transplant patients.
    Liburd EM; Pazderka V; Kovithavongs T; Dossetor JB
    Transplant Proc; 1978 Sep; 10(3):557-61. PubMed ID: 152490
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor-specific CML hyporesponsiveness after successful renal transplantation: studies on the mechanism.
    Thomas JM; Thomas FT; Hoffman S; Johns C; Mendez-Picon G; Lee HM
    Transplant Proc; 1979 Jun; 11(2):1258-9. PubMed ID: 157568
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of T-cell-mediated cytotoxic allograft response in human transplant recipients.
    Thomas J; Thomas F; Edwards E; Hoffman S; Lee HM
    Transplant Proc; 1981 Sep; 13(3):1594-8. PubMed ID: 6458130
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation.
    Harmon WE; Parkman R; Lavin PT; Grupe WE; Ingelfinger JR; Yunis EJ; Levey RH
    J Immunol; 1982 Oct; 129(4):1573-7. PubMed ID: 6213715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA regulates postrenal transplant CML nonreactivity.
    Goulmy E; Blokland E; Persijn G; Paul LC; Wilmink J; van Rood JJ
    J Immunol; 1985 Nov; 135(5):3082-6. PubMed ID: 3900203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressor cells and loss of in vitro killer cell inductiveness to donor cells in the peripheral blood lymphocytes of allograft recipients.
    Dossetor JB; Liburd EM; Kovithavongs T; Pazderka V
    Transplant Proc; 1979 Jun; 11(2):1260-2. PubMed ID: 157569
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of histocompatibility testing versus immunoreactive predisposition on kidney transplant survival.
    Kyriakides GK; Severyn W; Fuller L; Esquenazi V; Flaa C; Olson L; Miller J
    Surgery; 1982 Aug; 92(2):354-61. PubMed ID: 6213054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney transplantation by use of splenectomy and transfusions, cadaver haplotype matching, suppressor cell assays, and T-cell monitoring.
    Severyn W; Kyriakides G; Fuller L; Esquenazi V; Flaa C; Olson L; Goldsmith C; Miller J
    Surgery; 1981 Aug; 90(2):364-75. PubMed ID: 6454982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of demonstrable suppressor cell activity in a severe combined immunodeficiency patient with a sustained engraftment of DR-positive maternal T cells.
    Pollack MS; Kapoor N; Sorell M; Morishima Y; Dupont B; O'Reilly RJ
    Transplant Proc; 1981 Mar; 13(1 Pt 1):270-2. PubMed ID: 6455792
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppressor cells inhibiting the generation of cytotoxic T lymphocytes in long-term human transplant recipients.
    Thomas J; Johns C; Hoffmann S; Thomas F; Lee HM
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():87-9. PubMed ID: 158755
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of T cell sensitization in renal transplant patients with mixed lymphocyte culture-cell-mediated lympholysis.
    Suranyi MG; Hall BM; Duggin GG; Horvath JS; Johnson JR; Sheil AG; Tiller DJ
    Transplant Proc; 1987 Apr; 19(2):2873-5. PubMed ID: 2951917
    [No Abstract]   [Full Text] [Related]  

  • 13. Pretransplant dialysis and blood transfusion--correlation with cadaveric kidney graft survival.
    Fehrman I; Groth CG; Lundgren G; Magnusson G; Möller E
    Transplant Proc; 1979 Mar; 11(1):152-5. PubMed ID: 377622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the immunosuppressive effect of fractionated total lymphoid irradiation (TLI) vs conventional immunosuppression (CI) in renal cadaveric allotransplantation.
    Waer M; Vanrenterghem Y; Ang KK; Van der Schueren E; Michielsen P; Vandeputte M
    J Immunol; 1984 Feb; 132(2):1041-8. PubMed ID: 6228588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-specific decreased primary and secondary cell-mediated immune responses in patients with well functioning grafts.
    Pfeffer PF; Hirschberg H; Thorsby E
    Transplant Proc; 1981 Sep; 13(3):1604-6. PubMed ID: 6458131
    [No Abstract]   [Full Text] [Related]  

  • 16. [Autologous mixed lymphocyte culture (AMLC)].
    Volk HD; Grunow R
    Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pretransplant donor-specific transfusions in renal transplantation.
    Leivestad T; Flatmark A; Hirschberg H; Thorsby E
    Transplant Proc; 1982 Jun; 14(2):370-3. PubMed ID: 6214064
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA-D antigen disparity and HLA-DRw antibodies in intrafamilial renal allograft survival.
    Cochrum K; Hanes D; Van Speybroeck J; Perkins H; Ferrone S; Indeveri F; Amend W; Vincenti F; Feduska N; Salvatierra O
    Transplant Proc; 1979 Mar; 11(1):404-10. PubMed ID: 156426
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones.
    Vandekerckhove BA; Datema G; Koning F; Goulmy E; Persijn GG; Van Rood JJ; Claas FH; De Vries JE
    J Immunol; 1990 Feb; 144(4):1288-94. PubMed ID: 2137487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-specific blood transfusions (DST): clinical outcome and immunologic considerations.
    Fujiwara T; Sakagami K; Haisa M; Kusaka S; Uda M; Kobayashi N; Tanakaya K; Saito S; Matsuno T; Matsuoka J
    Transplant Proc; 1992 Aug; 24(4):1427-8. PubMed ID: 1386699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.